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background: Studies employing primary percutaneous intervention (PCI) in patients with ST segment elevation myocardial infarction 
(STEMI) have shown discordant results regarding the relative benefits of treating the culprit lesion only vs all significant stenosis. We 
performed a meta-analysis comparing PCI of routine culprit-only versus multi-vessel 1-stage PCI in STEMI.
methods: We conducted an electronic database searches of all published randomized controlled trials (RCT). Primary endpoint was all-
cause mortality. Secondary outcomes included recurrent myocardial infarction (MI) and repeat revascularization (RR). A fixed-effect model 
was used to obtain summary effect; if heterogeneity (I2)>40, estimates were obtained using a random-effects model.
results: Five RCT (n=1,136 patients) were included. There was no significant difference in all-cause mortality (odds ratio [OR] 0.68, 95% 
confidence interval [CI] 0.39 to 1.2; p 0.18). We found a significant benefit favoring multivessel 1-stage PCI for recurrent MI (OR 0.39, 95% 
CI 0.21 to 0.73; p 0.003) and RR (OR 0.41, 95% CI 0.28 to 0.6; p <0.001). No significant heterogeneity was seen. Exclusion of any single 
study from the analysis did not alter the overall result.
Conclusion:  In patients with STEMI with multi-vessel coronary disease, revascularization of all significant stenosis is associated with less 
recurrent MI and RR. These data add to the growing body of evidence favoring multi-vessel PCI in selected patient presenting with STEMI.
 
